Home › Immune System and Disorders › New York
Immune System and Disorders clinical trials in New York
14 studies for Immune System and Disorders are looking for participants at sites in New York.
Cities in New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Hematology Oncology Associates of Central New York-Auburn, Auburn
- Roswell Park Cancer Institute, Buffalo
- Hematology Oncology Associates of CNY at Camillus, Camillus
- and 5 more
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535Abatacept for the Treatment of Giant Cell Arteritis
- Hospital for Special Surgery, New York
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- NY Nephrology, Clifton Park
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
- Columbia University Irving Medical Center, New York
RecruitingPhase 2
All ages · All sexes · Updated Jun 2, 2026 · NCT05787574A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Columbia University, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Roswell Park Comprehensive Cancer Center, Buffalo
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078Biologics And Clinical Immunology Cohort at Sinai
- Mount Sinai, New York
RecruitingObservational study
Ages 12 and older · All sexes · Updated Feb 17, 2026 · NCT04784364BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
- Sun River Health, Beacon
- Bedford Stuyvesant Family Health Center, Brooklyn
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT05341726From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.